You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 16, 2025

Drug Price Trends for NDC 00093-1172


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 00093-1172

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for NDC 00093-1172

Understanding the National Drug Code (NDC)

The National Drug Code (NDC) is a unique three-segment number that identifies drugs in the U.S. market. For the NDC 00093-1172, the first segment is the labeler code, the second segment identifies the specific strength, dosage form, and formulation of the drug, and the third segment specifies the package size and type[4].

Market Context and Trends

The U.S. pharmaceutical market is projected to grow significantly, from $846.72 billion in 2022 to $1.28 trillion by 2030, with a Compound Annual Growth Rate (CAGR) of 5.36%. This growth is driven by factors such as rising pharmaceutical production capacity, greater approvals of generic drugs, and escalating R&D investments[2].

Pricing Mechanisms

For drugs covered under the Medicaid Drug Rebate Program, the pricing mechanism involves the Average Manufacturer Price (AMP) and the Unit Rebate Amount (URA). The 340B ceiling price, which is crucial for pricing drugs sold to certain covered entities, is calculated by subtracting the URA from the AMP and then adjusting for package size and case pack size[2].

Example Calculation

To illustrate, if the AMP for NDC 00093-1172 is $100 per unit, the URA is $20 per unit, the package size is 10 units, and the case pack size is 5 packages, the 340B ceiling price would be:

[ \text{340B Ceiling Price} = (\text{AMP} - \text{URA}) \times \text{Package Size} \times \text{Case Pack Size} ] [ \text{340B Ceiling Price} = (100 - 20) \times 10 \times 5 = \$4000 ]

Historical Pricing Data

Reviewing historical pricing data for NDC 00093-1172 is essential for understanding price trends. This data can be obtained from the FDA's NDC Directory and other sources. Historical data shows that prices in the U.S. have generally increased over the years, with an average price increase of 14% between 2017 and 2022, significantly higher than in other OECD countries[3].

Regulatory Changes

Regulatory changes can significantly impact drug pricing. Updates to the Medicaid Drug Rebate Program or new FDA guidelines can alter the pricing landscape. For instance, changes in rebate amounts or adjustments in the calculation of AMP and URA can directly affect the ceiling price of a drug[2].

Market Demand and Competition

The demand for the drug and the level of competition in the market are critical factors in price projections. If NDC 00093-1172 faces significant competition from generics or biosimilars, the price might stabilize or decrease over time. Conversely, if the drug has a unique formulation or high demand with limited competition, prices could remain high or even increase[2].

Technological Advancements

Technological advancements, such as the adoption of AI in drug discovery and manufacturing, can reduce development and manufacturing costs, potentially leading to lower prices. However, the impact of these advancements on the specific drug NDC 00093-1172 would depend on how these technologies are integrated into its production process[2].

International Price Comparisons

Prices for pharmaceuticals in the U.S. are significantly higher than in other countries. By 2022, prices in the U.S. were 5.5 times those in the OECD (excluding the U.S.) and 7.7 times prices in the rest of the world (excluding the U.S.). This disparity highlights the unique pricing dynamics in the U.S. market[3].

Price Projections for NDC 00093-1172

To project prices for NDC 00093-1172, consider the following factors:

  • Historical Pricing Data: Review past price trends to identify any patterns or anomalies.
  • Regulatory Changes: Monitor updates in regulatory policies that could affect pricing.
  • Market Demand and Competition: Assess the current market demand and the level of competition.
  • Technological Advancements: Evaluate the impact of new technologies on production costs.
  • International Comparisons: Consider the broader international pricing context, though this may have limited direct impact on U.S. pricing.

Given these factors, if NDC 00093-1172 is a widely used drug with moderate competition and no significant regulatory changes anticipated, the price might remain stable or see a modest increase. However, if the drug faces intense competition from generics or biosimilars, or if there are significant technological advancements, prices could decrease.

Example Scenario

If NDC 00093-1172 is a drug with high demand but moderate competition from generics, and there are no major regulatory changes or technological advancements expected, here is a hypothetical price projection:

  • Current AMP: $120 per unit
  • Current URA: $25 per unit
  • Package Size: 10 units
  • Case Pack Size: 5 packages

[ \text{Current 340B Ceiling Price} = (120 - 25) \times 10 \times 5 = \$4750 ]

Assuming a stable market and no significant changes, the future price could remain around this level. However, if competition increases or technological advancements reduce costs, the price could decrease.

Key Takeaways

  • NDC Directory: A critical resource for tracking and pricing drugs, updated daily by the FDA.
  • Pricing Mechanisms: AMP and URA are key in calculating ceiling prices for covered outpatient drugs.
  • Market Trends: The U.S. pharmaceutical market is growing, driven by increased production capacity, generic drug approvals, and R&D investments.
  • Price Projections: Historical data, regulatory changes, market demand, competition, and technological advancements influence price projections.
  • International Comparisons: U.S. drug prices are significantly higher than in other countries.

FAQs

Q: What is the National Drug Code (NDC) and its significance? A: The NDC is a unique three-segment number that identifies drugs in the U.S. market, crucial for tracking, pricing, and regulatory compliance[4].

Q: How is the 340B ceiling price calculated? A: The 340B ceiling price is calculated by subtracting the Unit Rebate Amount (URA) from the Average Manufacturer Price (AMP) and then adjusting by package size and case pack size[2].

Q: What factors influence price projections for pharmaceuticals? A: Historical pricing data, regulatory changes, market demand, competition, and technological advancements influence price projections[2].

Q: How does the FDA update the NDC Directory? A: The FDA updates the NDC Directory daily with information submitted by drug establishments in structured product labeling (SPL) electronic listing files[1].

Q: Why are NDC codes important for coders and billers? A: NDCs help ensure correct payment and control of drug costs, saving significant time and effort when verified correctly[4].

Sources

  1. FDA's National Drug Code Directory - FDA
  2. Latest pharmaceutical drug prices and trends for NDC 00093-7662 - Drug Patent Watch
  3. International Market Size and Prices - ASPE
  4. NDC Code Lookup - AAPC
  5. Prescription Drug Price Transparency Results and Recommendations - Oregon Drug Price Transparency Program
Last updated: 2025-01-18

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.